MOORE CAPITAL MANAGEMENT, LP - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 223 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2022. The put-call ratio across all filers is 1.73 and the average weighting 0.2%.

Quarter-by-quarter ownership
MOORE CAPITAL MANAGEMENT, LP ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q3 2022$14,943,000
+260.9%
226,782
+486.7%
0.35%
+328.0%
Q4 2021$4,140,000
-75.6%
38,654
-76.6%
0.08%
-68.3%
Q3 2021$16,971,000
-0.6%
165,069
-15.0%
0.26%
+7.0%
Q2 2021$17,080,000
+50.3%
194,183
+66.1%
0.24%
+69.2%
Q1 2021$11,367,000
-50.7%
116,911
-43.1%
0.14%
-43.5%
Q4 2020$23,042,000
+107.7%
205,454
+71.7%
0.25%
+19.3%
Q3 2020$11,092,000
+468.8%
119,652
+378.6%
0.21%
+307.7%
Q2 2020$1,950,000
-26.1%
25,000
-28.6%
0.05%
+8.3%
Q4 2017$2,639,00035,0000.05%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q4 2022
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 581,768$25,487,2569.57%
Casdin Capital, LLC 1,477,800$64,742,4185.02%
Nextech Invest Ltd. 188,228$8,246,2693.28%
DAFNA Capital Management LLC 261,235$11,444,7053.22%
Rock Springs Capital Management LP 1,891,510$82,867,0531.99%
HealthCor Management, L.P. 30,000$1,314,3001.20%
EFG Asset Management (North America) Corp. 110,853$4,766,6791.07%
Novo Holdings A/S 370,000$16,209,7001.01%
SECTORAL ASSET MANAGEMENT INC 115,900$5,077,5790.98%
EMERALD MUTUAL FUND ADVISERS TRUST 305,709$13,393,1110.83%
View complete list of BLUEPRINT MEDICINES CORP shareholders